Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02407977 · ClinicalTrials.gov registry record
Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation Therapy
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 13
- Enrollment target
NCT02407977 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 13 participants.
The verdict
NCT02407977 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This is an observational study. This protocol will determine the feasibility of using a novel nano-material based fiber-optic dosimeter (nanoFOD) device, with dimensions less than 1 mm wide, to measure real-time, pin-point, in-vivo radiation dose given during external beam delivery of radiation therapy treatments.This new protocol is similiar in design to Pro00050297 with the significant difference being the monitoring will be performed during external baem radiotherapy.
Interventions
- OTHER Novel nano-scintillatorfiber-optic dosimeter ( nanoFOD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-11-13 |
| Est. Completion | 2017-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02407977
The ClinicalTrials.gov registry entry for NCT02407977 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Novel nano-scintillatorfiber-optic dosimeter ( nanoFOD) is the first listed.
NCT02407977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02407977 about?
NCT02407977 is a clinical study titled "Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation Therapy". This is an observational study. This protocol will determine the feasibility of using a novel nano-material based fiber-optic dosimeter (nanoFOD) device, with dimensions less than 1 mm wide, to measure real-time, pin-point, in-vivo radiation dose given during external beam delivery of radiation ther...
What is the current status of trial NCT02407977?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-11-13. Estimated completion is 2017-04-19.
What interventions are being tested in trial NCT02407977?
The interventions under investigation include: Novel nano-scintillatorfiber-optic dosimeter ( nanoFOD) (OTHER).
Who is sponsoring clinical trial NCT02407977?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.